Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Vaccinations01:51

Vaccinations

53.1K
Overview
53.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Veins of Head and Neck01:19

Veins of Head and Neck

6.6K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Seroprevalence and stability of IgG antibodies to WU polyomavirus and human polyomavirus 6 among Finnish couples during a prospective follow-up.

Virology·2026
Same author

Complications of dermal filler treatments – a registry-based study from Finland.

Acta odontologica Scandinavica·2026
Same author

Diagnostic Accuracy of Salivary Periodontal Biomarkers Is Reduced in Patients With Crohn's Disease.

Clinical and experimental dental research·2026
Same author

Epstein-Barr virus serology in relation to the outcomes of oral and genital human papillomavirus infections in women during 3-year follow-up.

Scientific reports·2026
Same author

Ultrasound-enhanced fine-needle aspiration biopsy improves yield of solid benign parotid gland tumor tissue: a pilot study.

European radiology experimental·2026
Same author

Malignant Transformation of Oral Epithelial Dysplasia in Southern Finland.

Head & neck·2026

Related Experiment Video

Updated: Mar 14, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.4K

Vaccination Expectations in HNSCC.

Stina Syrjänen1, Jaana Rautava2

  • 1Department of Oral Pathology, Faculty of Medicine, Turku University Hospital, Institute of Dentistry, University of Turku, Lemminkäisenkatu 2, 20520, Turku, Finland. stina.syrjanen@utu.fi.

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|October 5, 2016
PubMed
Summary

Current human papillomavirus (HPV) vaccinations may help prevent HPV-associated head and neck cancers. However, HPV infection is complex, and early life acquisition raises new vaccination questions.

Keywords:
Head and neck squamous cell carcinoma (HNSCC)Human papillomavirus (HPV)Vaccination

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.4K
Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

10.4K

Related Experiment Videos

Last Updated: Mar 14, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.4K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.4K
Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
07:43

Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples

Published on: July 29, 2017

10.4K

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Head and neck squamous cell carcinoma (HNSCC), particularly oropharyngeal cancer, shows a rising incidence in industrialized nations.
  • Existing anogenital human papillomavirus (HPV) vaccination programs suggest potential efficacy against HNSCC.

Purpose of the Study:

  • To explore the potential effectiveness of current HPV vaccinations against HNSCC.
  • To address the complexities of HPV infection beyond sexual transmission and its implications for vaccination strategies.

Main Methods:

  • Review of existing data on HPV vaccination and HNSCC epidemiology.
  • Analysis of HPV infection pathways, including non-sexual transmission routes.
  • Consideration of early-life HPV acquisition and its immunological consequences.

Main Results:

  • HPV vaccination shows promise for HNSCC prevention, drawing parallels with anogenital vaccination success.
  • HPV infection is more intricate than previously understood, involving transmission via semen, placenta, and early-life exposure.
  • Neonatal HPV infections can establish cell-mediated immunity (CMI) and T memory cells.

Conclusions:

  • While promising, HPV vaccination for HNSCC requires further investigation due to differences in carcinogenesis between anatomical sites.
  • The complex nature of HPV transmission and early-life immunity necessitates a re-evaluation of HPV vaccination approaches.
  • Further research is crucial to optimize HPV vaccination strategies for head and neck cancer prevention.